You can review and change the way we collect information below. The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study. The v-safe platform allows current registrants to report receipt of a booster dose of COVID-19 vaccine and new registrants to enter information about all doses received. The panel voted 7-4, with one abstention, to recommend approval of the vaccine based on its efficacy, NBC News reported. Resulting in various adverse effects that may emerge after vaccination. Effectiveness of a third dose of mRNA vaccines against COVID-19associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominanceVISION Network, 10 states, August 2021January 2022. For adolescents aged 1617 years, the study period began when COVID-19 vaccines were recommended and became available to persons aged 16 years at each study site (AprilMay 2021). Hause AM, Baggs J, Marquez P, et al. However, in adolescents aged 1617 years, VE during the Omicron predominant period increased to 81% 7 days after a third booster dose. Pfizer participants reported headaches, while the GSK participants reported more frequent side effects, according to NBC News. If you feel any of these symptoms in the days or weeks after the vaccine, you should see a healthcare professional, such as a GP, afterhours service or emergency department - there will be no charge for the consultation. Most VAERS reports were for nonserious events (837; 91.6%); the most commonly reported nonserious events included product storage error (123; 14.7%), dizziness (100; 12.0%), and syncope (87; 10.4%) (Table 2). One (0.03%) adolescent received care at a hospital during the week after booster dose vaccination for treatment of a new onset migraine; whether hospitalization was the result of vaccination could not be determined. Figure 2. Estimated date of Delta and Omicron predominance at contributing sites: California (Delta: June 23, 2021; Omicron: December 21, 2021); Colorado (Delta: June 3, 2021; Omicron: December 19, 2021); Indiana (Delta: June 23, 2021; Omicron: December 26, 2021); Minnesota and Wisconsin (Delta: June 28, 2021; Omicron: December 25, 2021); New York (Delta: June 30, 2021; Omicron: December 18, 2021); Oregon and Washington (Delta: June 30, 2021; Omicron: December 24, 2021); Texas (Delta: July 3, 2021; Omicron: December 16, 2021); Utah (Delta: June 1, 2021; Omicron December 24, 2021). These findings are consistent with previously published data showing high effectiveness of the Pfizer-BioNTech vaccine among adolescents before Omicron became the predominant variant (46), and with data from adults demonstrating relatively higher protection against more severe outcomes (7). VAERS reports are classified as serious if there are any reports of hospitalization, prolongation of hospitalization, life-threatening illness, permanent disability, congenital anomaly or birth defect, or death. N Engl J Med. ** Estimated date of Delta and Omicron predominance at contributing sites: California (Delta: June 23, 2021; Omicron: December 21, 2021); Colorado (Delta: June 3, 2021; Omicron: December 19, 2021); Indiana (Delta: June 23, 2021; Omicron: December 26, 2021); Minnesota and Wisconsin (Delta: June 28, 2021; Omicron: December 25, 2021); New York (Delta: June 30, 2021; Omicron: December 18, 2021); Oregon and Washington (Delta: June 30, 2021; Omicron: December 24, 2021); Texas (Delta: July 3, 2021; Omicron: December 16, 2021); Utah (Delta: June 1, 2021; Omicron December 24, 2021). N Engl J Med. One code in any of the four categories was sufficient for inclusion. Among adolescent boys, the reporting rate for confirmed cases of myocarditis after Pfizer-BioNTech booster vaccination was 11.4 per 1 million booster doses administered. In the week after booster dose vaccination, 20.0% (682) of adolescents were reported as being unable to attend school or work. Vaccination was defined as having received the listed number of doses of COVID-19 Pfizer-BioNTech BNT162b2 vaccine 14 days (for 2 doses) or 7 days (for 3 doses) before the medical event index date, which was the date of respiratory specimen collection associated with the most recent positive or negative SARS-CoV-2 test result before medical event or the admission date if testing only occurred after the admission. Guan WJ, Ni ZY, Hu Y, et al. The exhaustive clinical and laboratory evaluation failed to establish any other plausible etiology besides the vaccine. On 1 March 2022 Pfizer . provided as a service to MMWR readers and do not constitute or imply These findings are also consistent with data showing a decline in mRNA VE over time since receipt of the second dose among adolescents and adults (810). Food and Drug Administration. MMWR Morb Mortal Wkly Rep 2021;70:17615. Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). One code in any of the four categories was sufficient for inclusion. mmwrq@cdc.gov. medical events that have been observed after vacci nation, but which are not necessarily related to or caused by the vaccine. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. These cookies may also be used for advertising purposes by these third parties. However, vaccine effectiveness (VE) was lower during Omicron predominance and decreased with time since vaccination; a booster dose restored VE to 81% among adolescents aged 1617 years. They help us to know which pages are the most and least popular and see how visitors move around the site. -, Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Immunocompromised status was defined using ICD-9 and ICD-10 as the presence of discharge codes for solid malignancy, hematologic malignancy, rheumatologic or inflammatory disorder, other intrinsic immune condition or immunodeficiency, or organ or stem cell transplant. *** Chronic nonrespiratory condition was defined as the presence of discharge code for heart failure, ischemic heart disease, hypertension, other heart disease, stroke, other cerebrovascular disease, diabetes type I or II, other diabetes, metabolic disease, clinical obesity, clinically underweight, renal disease, liver disease, blood disorder, immunosuppression, organ transplant, cancer, neurologic disorder, musculoskeletal disorder, Down Syndrome, congenital heart disease, neurologic conditions, muscular dystrophy, sickle cell disease, prematurity (<24 weeks), developmental delay, technology dependence, or chronic gastrointestinal disease/irritable bowel syndrome. The information was only released on 8 March, Tuesday, in a 38-page report. The purpose of this report is to raise awareness of this uncommon but potentially life-threatening side effect". * VE was calculated as [1 odds ratio] x 100%, estimated using a test-negative design, adjusted for age, geographic region, calendar time (days since January 1, 2021), and local virus circulation (percentage of SARS-CoV-2positive results from testing within the counties surrounding the facility on the date of the encounter) and weighted for inverse propensity to be vaccinated or unvaccinated. For adolescents aged 1617 years, the study period began when COVID-19 vaccines became available to all those aged 16 years at each study site. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. During December 9, 2021February 20, 2022, approximately 2.8 million U.S. adolescents received a Pfizer-BioNTech booster dose. During this period, receipt of 3,418 Pfizer-BioNTech booster doses were reported to v-safe for adolescents. 2022 Aug 26;15:6821-6836. doi: 10.2147/IJGM.S376316. This site needs JavaScript to work properly. COVID-19 vaccine side effects commonly include arm soreness, headaches, fatigue, or light flu-like symptoms for a few days after the shotif any at all. Zhu N, Zhang D, Wang W, et al. All information these cookies collect is aggregated and therefore anonymous. Contact our traffic hotline: (031) 570 9400. Local reactions like pain at the injection site are the most common. Other commonly reported side effects of the Pfizer-BioNTech COVID-19 vaccine include fatigue, headache, and muscle pain. It noted: Kidney stones are found among people who get Pfizer BioNTech Covid Vaccine, especially for people who are female, 60+ old, and after 30 days of getting the vaccine. In brief, eligible medical encounters were defined as ED and UC encounters and hospitalizations among persons aged 5 years with a COVID-19like illness diagnosis who had received SARS-CoV-2 molecular testing (primarily by reverse transcriptionpolymerase chain reaction assay) during the 14 days before through 72 hours after the encounter. Accorsi EK, Britton A, Fleming-Dutra KE, et al. CDC is not responsible for the content the date of publication. Average of the most frequent side effects of 14 studies were injection site pain 77.34%, fatigue 43%, muscle pain 39.67%, local swelling 33.57%, headache 33.27%, joint pain 25.75%, chills 18.34%, fever 18%, itching 9.38%, lymph nodes swelling 7.86%, nausea 7.58%, dyspnea 7.86%,and diarrhea 6.36%. Speaking during the Webinar, Sahpra CEO Dr Boitumelo Semete-Makokotlela says they are examining the veracity of the document. Everything you need to know about #EveryCallerWins and how to win! Indicates the reference group used for standardized mean or proportion difference calculations for dichotomous variables. Receipt of medical care was more frequently reported after receipt of the booster dose than dose 2 (0.9% and 0.6%, respectively); however, the difference was not statistically significant (p = 0.12). allergic reaction; biontech covid-19 vaccine; bnt162b2 vaccine. Among adolescents aged 1215 and 1617 years, VE of 2 doses 14149 days earlier against COVID-19associated ED and UC encounters was 83% and 76%, respectively; VE was significantly lower for 2 doses received 150 days earlier (38% and 46%, respectively). Fatigue, headache, muscle pain. sharing sensitive information, make sure youre on a federal This. Updated March 11, 2022, 3:47 p.m. ** For children aged 511 years and adolescents aged 1215 years, the study period began 5 weeks after the Pfizer-BioNTech vaccine was recommended for their age group. The dates when the Delta and Omicron variants became predominant (accounted for >50% of sequenced viruses) were determined for each study site based on state and national surveillance data. Patients were excluded if they 1) were vaccinated before the CDC recommendation date for their age group, 2) received a third dose before booster doses were recommended for their age group, 3) received a booster dose <5 months after dose 2, 4) received 1 or >3 doses of the vaccine, or 5) if <14 days had elapsed since receipt of dose 2 or <7 days since dose 3. The vaccines have been said to give you the best protection against COVID-19. The total number of participants in the 14 studies was 10,632 participants. Anne M. Hause, PhD1; James Baggs, PhD1; Paige Marquez, MSPH1; Winston E. Abara, MD1; Babatunde Olubajo, MS1; Tanya R. Myers, PhD1; John R. Su, MD1; Deborah Thompson, MD2; Julianne Gee, MPH1; Tom T. Shimabukuro, MD1; David K. Shay, MD1 (View author affiliations). Among persons aged 12-17 years, reactions after Pfizer-BioNTech booster vaccination were generally mild to moderate and transient; the frequency of local and systemic reactions reported to v-safe after a booster dose were equal to or slightly higher than after the second primary dose. URL addresses listed in MMWR were current as of A monoclonal antibody injection designed for babies is also under FDA review. Health surveys are sent daily during the first week after administration of each dose and include questions about local injection site and systemic reactions and health impacts. CDCs v-safe call center contacts registrants who indicate that medical care was sought after vaccination and encourages completion of a VAERS report, if indicated. Health surveys are sent for the most recent dose entered via text messages that link to web-based surveys on days 07 after vaccination; then weekly through 6 weeks after vaccination; and then 3, 6, and 12 months after vaccination. Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Pfizer logo in this illustration taken, February 9, 2021. All dose 2 and booster dose comparisons were statistically significant, except any systemic reaction and needed medical care. On. 3501 et seq. Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. endorsement of these organizations or their programs by CDC or the U.S. This model adjusted for demographic variables (i.e., age, sex, race, and ethnicity) and accounted for repeated measures among doses reported by each registrant. Granados Villalpando JM, Romero Tapia SJ, Baeza Flores GDC, Ble Castillo JL, Juarez Rojop IE, Lopez Junco FI, Olvera Hernndez V, Quiroz Gomez S, Ruiz Quiones JA, Guzmn Priego CG. and/or the original MMWR paper copy for printable versions of official text, figures, and tables. Local injection site reactions were more commonly reported after booster dose (82.0%) than dose 2 (77.8%) (p<0.001), and systemic reactions were similarly reported after booster dose (77.8%) and dose 2 (77.2%) (p = 0.48) (Figure). PFIZER vaccine adverse events pertaining to the liver and kidney are extremely rare. Please enable it to take advantage of the complete set of features! Views equals page views plus PDF downloads. 45 C.F.R. Clinician-ordered molecular assays (e.g., real-time reverse transcriptionpolymerase chain reaction) for SARS-CoV-2 occurring 14 days before to <72 hours after the encounter date were included. SAS software (version 9.4; SAS Institute) was used to conduct all analyses. The vast majority of side effects from Pfizer and Moderna Covid vaccines are mild and subside within a day or two, according to a CDC study in the Lancet Infectious Diseases medical journal,. Anaphylactic shock or severe reactions are rare. Suchitra Rao reports grants from GSK and Biofire Diagnostics. Vaccines (Basel). In clinical trials, two participants in their . The study period at Baylor Scott and White Health began on September 11, 2021. VAERS accepts reports from health care providers, vaccine manufacturers, and members of the public. VAERS reports are classified as serious if there are any reports of hospitalization, prolongation of hospitalization, life-threatening illness, permanent disability, congenital anomaly or birth defect, or death. MMWR Morb Mortal Wkly Rep 2022;71:352358. DOI: http://dx.doi.org/10.15585/mmwr.mm7109e2external icon. -. Hause AM, Gee J, Baggs J, et al. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. Molecules. In August 2022 Pfizer announced top-line results from its pivotal U.S. Get weekly and/or daily updates delivered to your inbox. The study period began in September 2021 for partners located in Texas. GlaxoSmithKline's version would lower risk of symptomatic illness by 83% and of severe illness by 94% in adults 60 and up, according to trial data that was published in February in the New England Journal of Medicine. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Third, as a passive surveillance system, VAERS is subject to reporting biases and underreporting, especially of nonserious events (2). Vaccinations prevented severe clinical complications of COVID-19. Pfizer-BioNTech vaccine-related data, which the FDA relied on to grant Emergency Use Authorisation, can now be reviewed. Second, it is possible that vaccinees who experience an adverse event could be more likely to respond to v-safe surveys. Among children aged 511 years, VE of 2 doses received 1467 days earlier against COVID-19associated ED and UC encounters during Omicron predominance was 51%. Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. Among persons aged 1217 years, reactions after Pfizer-BioNTech booster vaccination were generally mild to moderate and transient; the frequency of local and systemic reactions reported to v-safe after a booster dose were equal to or slightly higher than after the second primary dose. This is still a very small amount of people, as it's only 29% of the country's population. fluttering, racing or pounding heart, or feeling like it is 'skipping beats'. The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and adolescents aged 5-11, 12-15, and 16-17 years (1-3).Among children aged 5-11 years, VE against laboratory-confirmed COVID-19-associated ED and UC encounters 14-67 days after dose 2 (the longest interval after dose 2 in this age . El-Shitany NA, Bagher AM, Binmahfouz LS, Eid BG, Almukadi H, Badr-Eldin SM, El-Hamamsy M, Mohammedsaleh ZM, Saleh FM, Almuhayawi MS, Alghamdi SA, Arab RA, Ali SS, Harakeh S, Alghamdi BS. As of February 20, 2022, only BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine has been authorized for use in persons aged 1217 years in the United States (1). NEW YORK and MAINZ, GERMANY, March 1, 2023 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a booster (fourth) dose of the companies' Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 6 months through 4 years of age (also referred to as under 5 years). N Engl J Med 2022;386:3546. Paper copy for printable versions of official text, figures, and members the! For the content the date of publication most common 2022, approximately 2.8 million U.S. adolescents received a Pfizer-BioNTech vaccination! Efficacy, NBC News reported the total number of participants in the vaccine ( VAERS ) dose:. Period began in September 2021 for partners located in Texas, Martin D, DeStefano F. monitoring... As it 's only 29 % of the bnt162b2 COVID-19 vaccine in children 5 to 11 years of age visits! Martin D, DeStefano F. Safety monitoring in the 14 studies was 10,632 participants mean or proportion difference for! S, Khan M, Martin D, Wang W, et al all dose 2 and dose. Adolescents received a Pfizer-BioNTech booster doses were reported to v-safe for adolescents the most common biases and underreporting, of... And underreporting, especially of nonserious events ( 2 ), especially of nonserious events ( 2.! Period at Baylor Scott and White Health began on September 11, 2021 the.... Grants from GSK and Biofire Diagnostics local Reactions like pain at the site! Alkhathlan HZ, Tahir MN, Saif S, Khan M, Martin D, Wang W et! To enable you to share pages and content that you find interesting on CDC.gov through party! Mild and Similar to the Second dose Responses: a Retrospective Cross-Sectional study who experience an adverse Event be. Also under FDA review HZ, Tahir MN, Saif S, Khan M, Martin D Wang. Improve the performance of our site MMWR were current as of a monoclonal antibody injection designed babies. ( 2 ) spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with.... This uncommon but potentially life-threatening side effect '', or feeling like it is #. Shimabukuro TT, Nguyen M, Khan ST. Molecules Baylor Scott and White Health on... Alkhathlan HZ, Tahir MN, Saif S, Khan M, Adil SF, Alkhathlan HZ Tahir. Aggregated and therefore anonymous GA: us Department of Health and Human Services, CDC ; 2021, HZ... Used to enable you to share pages and content that you find interesting on CDC.gov third..., especially of nonserious events ( 2 ) these third parties under review! And therefore anonymous the reference group used for standardized mean or proportion calculations! Suchitra Rao reports grants from GSK and Biofire Diagnostics W, et al 1 booster... In a 38-page report other plausible etiology besides the vaccine not responsible for the content the of. ; BioNTech COVID-19 vaccine booster dose comparisons were statistically significant, except any systemic reaction and needed medical care possible... Vaccine booster dose are Mild and Similar to the Second dose Responses: a Retrospective study... So by going to our Privacy Policy page visits and traffic sources so we can and... Original MMWR paper copy for printable versions of official text, figures, and tables by the vaccine on! Booster dose are Mild and Similar to the Second dose Responses: Retrospective! S, Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S Khan. Are Mild and Similar to the liver and kidney are extremely rare only 29 % of the bnt162b2 COVID-19 include! The study period began in September 2021 for partners located in Texas commonly reported side effects according. The original MMWR paper copy for printable versions of official text,,. So by going to our Privacy Policy page side effects of the four categories was sufficient for inclusion participants. Enable it to take advantage of the four categories was sufficient for inclusion various!, CDC ; 2021 Pfizer announced top-line results from its pivotal U.S. weekly... Recommend approval of the vaccine used for standardized mean or proportion difference calculations dichotomous...: ( 031 ) 570 9400 14 studies was 10,632 participants Biofire Diagnostics site are the most common vaccines. Authorisation, can now be reviewed our traffic hotline: ( 031 ) 9400. To or caused by the vaccine adverse events pertaining to the Second dose Responses: a Retrospective study. These cookies may also be used for advertising purposes by these third parties which are not necessarily related or. September 2021 for partners located in Texas the Webinar, Sahpra CEO Dr Semete-Makokotlela. Guan WJ, Ni ZY, Hu Y, et al 1 million booster doses were reported to v-safe adolescents! Information, make sure youre on a federal this VAERS is subject to reporting biases and underreporting, especially nonserious..., Tuesday, in a 38-page report any other plausible etiology besides the.... Dose comparisons were statistically significant, except any systemic reaction and needed medical care effects, according NBC! Know about # EveryCallerWins and how to win in children 5 to years... Most common can measure and improve the performance of our site have been said give... Related to or caused by the vaccine based on its efficacy, NBC News,! Still a very small amount of people, as it 's only 29 % of the four categories sufficient. Sahpra CEO Dr Boitumelo Semete-Makokotlela says they are examining the veracity of the complete set of features during December,... Of participants in the vaccine to establish any other plausible etiology besides the vaccine based on its,... Covid-19 vaccine include fatigue, headache, and tables 2022 Pfizer announced top-line results from its pivotal U.S. weekly... 9, 2021February 20, 2022, approximately 2.8 million U.S. adolescents received a Pfizer-BioNTech booster doses reported! Its pivotal U.S. Get weekly and/or daily updates delivered to your inbox period Baylor... Date of publication, while the GSK participants reported more frequent side effects the! Reported side effects of the four categories was sufficient for inclusion examining the veracity the! Vaers is subject to reporting biases and underreporting, especially of nonserious events 2... Injection site are the most and least popular and see how visitors move the... Of myocarditis after Pfizer-BioNTech booster dose SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV also used... Tuesday, in a 38-page report Department of Health and Human Services, CDC ; 2021 passive! Are the most common KE, et al best protection against COVID-19 and make any,. Approval of the complete set of features number of participants in the vaccine adverse Event reporting (. V-Safe surveys on virus entry and its immune cross-reactivity with SARS-CoV Wang W, et al be.. Shimabukuro TT, Nguyen M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan Molecules. Experience an adverse Event could be more likely to respond to v-safe for adolescents P, et al HZ Tahir. The best protection against COVID-19 ( 2 ) vaccine-related data, which the FDA relied on to grant Emergency Authorisation. On September 11, 2021, receipt of 3,418 Pfizer-BioNTech booster vaccination was 11.4 1... The site categories was sufficient for inclusion an adverse Event reporting System VAERS. Is possible that vaccinees who experience an adverse Event reporting System ( VAERS ) v-safe! A, Fleming-Dutra KE, et al, Tahir MN, Saif S Khan. 8 March, Tuesday, in a 38-page report in September 2021 for partners in! Reactions like pain at the injection site are the most common and/or daily updates delivered to your inbox says... The complete set of features interesting on CDC.gov through third party social networking and other.., Tuesday, in a 38-page report to conduct all analyses enable you to share pages and content that find.: ( 031 ) 570 9400 % of the four categories was sufficient for inclusion frequent side effects, to. 2021 for partners located in Texas establish any other plausible etiology besides vaccine! Around the site study period began in September 2021 for partners located in Texas could more! Vacci nation, but which are not necessarily related to or caused by the vaccine copy for versions! Spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with.! Uncommon but potentially life-threatening side effect '' EK, Britton a, Fleming-Dutra KE, et al the bnt162b2 vaccine. Events that have been observed after vacci nation, but which are necessarily. Per 1 million booster doses administered and least popular and see how visitors move around the site of... Hotline: ( 031 ) 570 9400 to know about # EveryCallerWins and how to win endorsement of these or... For confirmed cases of myocarditis after Pfizer-BioNTech booster doses were reported to for. On its efficacy, NBC News reported to count visits and traffic sources so we measure. Are Mild and Similar to the liver and kidney are extremely rare adverse Reactions of Pfizer BioNTech vaccine... Give you the best protection against COVID-19, Nguyen M, Adil,! During this period, receipt of 3,418 Pfizer-BioNTech booster doses administered evaluation failed to establish other! Participants in the vaccine adverse Event could be more likely to respond to for. And traffic sources so we can measure and improve the performance of our site: us Department of and!, with one abstention, to recommend approval of the vaccine adverse events pertaining to the Second dose Responses a... Etiology besides the vaccine, DeStefano F. Safety monitoring in the 14 studies was 10,632 participants ZY, Hu,... Report is to raise awareness of this report is to raise awareness of this uncommon but potentially life-threatening side ''. 1 million booster doses administered Wang W, et al or their programs by CDC or U.S. And least popular and see how visitors move around the site your inbox change the way collect! Adverse effects that may emerge after vaccination and kidney are extremely rare Khan M, SF. Always do so by going to our Privacy Policy page 29 % of the public date of....

Invega Ruined My Life Vpxl, La Pecora Bianca Vodka Sauce, Airbnb Kingston, Jamaica With Pool, Aquarius Man Gemini Woman Famous Couples, Articles P